| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10620-017-4599-6 |
| P698 | PubMed publication ID | 28551709 |
| P50 | author | Nicholas Talley | Q7026286 |
| Gerald J. Holtmann | Q37834742 | ||
| Michael Jones | Q56554502 | ||
| Natasha Koloski | Q88169411 | ||
| P2093 | author name string | A Shah | |
| J Hammer | |||
| N Martin | |||
| D Burger | |||
| H Hoelz | |||
| M Kutyla | |||
| M von Wulffen | |||
| S R Gurusamy | |||
| P2860 | cites work | The hospital anxiety and depression scale | Q27860968 |
| Impact of functional gastrointestinal disorders on survival in the community | Q33919405 | ||
| Who is targeted for lifestyle advice? A cross-sectional survey in two general practices | Q34217477 | ||
| Clinical assessment of irritable bowel syndrome | Q34787577 | ||
| Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease | Q37118125 | ||
| Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. | Q37124512 | ||
| Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease | Q38475858 | ||
| The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study | Q39665748 | ||
| Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials | Q39826545 | ||
| Irritable bowel syndrome in office-based practice in the United States | Q41878297 | ||
| Evaluation of model fit in nonlinear multilevel structural equation modeling | Q41994843 | ||
| Development and validation of a new disease severity index: the Inflammatory Bowel Disease Index (IBDEX) | Q42293565 | ||
| Framework to assess the effects of using patient-reported outcome measures in chronic care management | Q44581445 | ||
| Complicated and uncomplicated peptic ulcer disease: altered symptom response to a nutrient challenge linked to gastric motor dysfunction | Q45829023 | ||
| Patient-provider sex and race/ethnicity concordance: a national study of healthcare and outcomes | Q46054139 | ||
| International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease | Q46138749 | ||
| Intensity of Chronic Pain--The Wrong Metric? | Q47900656 | ||
| Patient reported outcome measures in practice | Q48049891 | ||
| Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: a gender issue? | Q48553563 | ||
| Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index | Q48768618 | ||
| Non-medical influences on medical decision-making. | Q51025833 | ||
| Reliability and validity of the PAS-ADD Checklist for detecting psychiatric disorders in adults with intellectual disability. | Q51993728 | ||
| Physician treatment of men and women patients: sex bias or appropriate care? | Q52875740 | ||
| Gender bias in the diagnosis of COPD. | Q52932156 | ||
| Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. | Q52981020 | ||
| Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population | Q57840344 | ||
| The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress | Q60707901 | ||
| Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice | Q61890795 | ||
| Assessment of functional gastrointestinal disease: the bowel disease questionnaire | Q68591715 | ||
| Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist | Q71434915 | ||
| The relation between pain beliefs, negative thoughts, and psychosocial functioning in chronic pain patients | Q73427541 | ||
| The 'difficult patient' as perceived by family physicians | Q74626883 | ||
| Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study | Q77118894 | ||
| Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders | Q79490044 | ||
| Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe | Q83178704 | ||
| P2507 | corrigendum / erratum | Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting | Q48156514 |
| P433 | issue | 8 | |
| P304 | page(s) | 1913-1922 | |
| P577 | publication date | 2017-05-27 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting | |
| P478 | volume | 62 |
| Q92251101 | Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome |
| Q97646519 | Effects of taurocholic acid metabolism by gut bacteria: A controlled feeding trial in adult African American subjects at elevated risk for colorectal cancer |
| Q47141166 | Improving Quality of Care in Patients with Liver Cirrhosis |
| Q58110565 | Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors |
| Q44278685 | Patient-Reported Outcome Measures in Routine Clinical Care: The PROMise of a Better Future? |
| Q48156514 | Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting | main subject | P921 |
Search more.